When.com Web Search

  1. Ads

    related to: used 2023 nissan maxima platinum

Search results

  1. Results From The WOW.Com Content Network
  2. List of Nissan vehicles - Wikipedia

    en.wikipedia.org/wiki/List_of_Nissan_vehicles

    2023 Global Two-row compact crossover SUV (C-segment). Three-row available in several markets. ... 1980–2023 Nissan Maxima; 1982–2004 Nissan Prairie; 1984–1987 ...

  3. Nissan Maxima - Wikipedia

    en.wikipedia.org/wiki/Nissan_Maxima

    The Nissan Maxima was discontinued from the Mexican market after the 2020 model year. For the US and Canada, Nissan ended production of the Maxima in 2023. However, the Maxima name could be used on an upcoming electric sedan which will get an Infiniti equivalent. [36] Performance: [37] 0–60 mph (0–97 km/h): 5.9 sec.

  4. 2023 Nissan Maxima signs off with price increases, not ... - AOL

    www.aol.com/news/2023-nissan-maxima-signs-off...

    The bell tolls for the Nissan Maxima, ending its current ICE incarnation sometime in its 42nd year. It gets price increases. Will it come back as an EV?

  5. Nissan Altima - Wikipedia

    en.wikipedia.org/wiki/Nissan_Altima

    Nissan estimates the 2.5-liter fuel economy to be 27 city/38 hwy and the 3.5-liter V6 at 22 city/30 hwy thanks to its refined CVT that has been lightened by 8 lbs. Most of the major mechanical components of this generation Altima are carried over. [38] Much of the exterior styling seems to draw familiar traits from the Nissan Maxima. [38]

  6. Nissan - Wikipedia

    en.wikipedia.org/wiki/Nissan

    Nissan Cabstar (日産・キャブスター Nissan Kyabusutā) is the name used in Japan for two lines of pickup trucks and light commercial vehicles sold by Nissan and built by UD Nissan Diesel, a Volvo AB company and by Renault-Nissan Alliance for the European market. The name originated with the 1968 Datsun Cabstar, but this was gradually ...

  7. Stem cell therapy to correct heart failure in children could ...

    www.aol.com/stem-cell-therapy-correct-heart...

    Doctors and specialists at the Murdoch Children's Research Institute in Melbourne, Australia, are studying and reprogramming the potential of the blood to treat heart failure in children.